Cipla has reported results for the fourth quarter and year ended March 31, 2018. 

The company has reported over 8-fold jump in its net profit at Rs 224.81 crore for the quarter ended March 31, 2018 as compared to Rs 25.86 crore for the same quarter in the previous year. Total income of the company increased by 2.65% at Rs 2,788.22 crore for quarter under review as compared to Rs 2,716.36 crore for the quarter ended March 31, 2017.

On consolidated basis, the company has reported net profit of Rs 178.61 crore for the quarter ended March 31, 2018 as compared to net loss of Rs 61.79 crore for the corresponding quarter in the FY17. Total consolidated income of the company rose 3.69% at Rs 3,737.98 crore for quarter under review as compared to Rs 3,604.79 crore for the same quarter ended previous year.

For the year ended March 31, 2018, the company has posted a rise of 50.63% in its net profit at Rs 1,468.52 crore as compared to Rs 974.94 crore for the previous year. Total income of company increased 6.08% at Rs 11,779.69 crore for year under review as compared to Rs 11,104.43 crore for the year ended March 31, 2017.

For the year ended March 31, 2018, on the consolidated basis, the company has posted rise of 40.16% in its net profit at Rs 1,410.53 crore as compared to Rs 1,006.39 crore for the previous year. Total consolidated income of company increased by 4.83% at Rs 15,576.90 crore for year under review as compared to Rs 14,858.93 crore for the year ended March 31, 2017.

Cipla Share Price

1466.05 -0.10 (-0.01%)
12-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1736.85
Dr. Reddys Lab 1215.65
Cipla 1466.05
Zydus Lifesciences 895.00
Lupin 2189.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×